View selected publications citing GeneCopoeia's AAV products and services from the recent literature
2021
- Toan, N.K., et al. (2021). Choline Acetyltransferase Induces the Functional Regeneration of the Salivary Gland in Aging SAMP1/Kl -/- Mice. International Journal of Molecular Sciences doi: 10.3390/ijms22010404 [AAVPrime™ AAV particles expressing shRNA targeting ChAT]
- Zhang, W-B., et al. (2021). Activation of Nrf2 by miR-152 Inhibits Doxorubicin-InducedCardiotoxicity via Attenuation of Oxidative Stress, Inflammation,and Apoptosis. Oxidative Medicine and Cellular Longevity doi: 10.1155/2021/8860883 [AAVPrime™ AAV particles expressing mir-152 miRNA; AAVPrime™ AAV particles expressing shRNA targeting Nrf2]
- Kang, S.S., et al. (2021). ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer’s disease. Acta Neuropathologica doi: 10.1007/s00401-021-02315-1 [AAVPrime™ AAV particles expressing ApoE4]
- Quan, D.N. and Shiloach, J. (2021). rAAV production and titration at the microscale for high- throughput screening. Human Gene Therapy doi: 10.1089/hum.2021.080 [AAVPrime™ AAV particles expressing EGFP]
2020
- Han, L., et al. (2020). Homocysteine-induced electrical remodeling via the mediation of IP3R1/Nav1.5 signaling pathway. Am J Transl Res. 2020; 12(7): 3822–3841 [AAVPrime™ AAV particles expressing shRNA targeting IP3R1]
- Luo, Y., et al. (2020). Upregulation of circ_0000199 in circulating exosomes is associated with survival outcome in OSCC. Scientific Reports doi: 10.1038/s41598-020-70747-y [AAVPrime™ AAV particles expressing shRNA targeting circ_0000199]
- Luo, Y., et al. (2020). A novel epigenetic regulation of circFoxp1 on Foxp1 in colon cancer cells. Cell Death & Disease doi: 10.1038/s41419-020-03007-6 [AAVPrime™ AAV particles expressing shRNA targeting circ_FoxP1]
- Millett, P.J., et al. (2020). Gene Editing to Impove Joint Function. United States Patent Applicaitons doi: 20200360454K [AAVPrime™ AAV particles expressing GFP]
2019
- Zhao, Y. and Ren, J. (2019). MODIFIED IMMUNE CELLS HAVING ENHANCED FUNCTION AND METHODS FOR SCREENING FOR SAME. United States Patent Application 20190345491 [AAVPrime™ AAV particles expressing DNMT3A]